Pruritus burden assessment in severe atopic dermatitis patients under dupilumab: response predictor?

Brás, R; Limão, R; Pedro, E; Lopes, A

Brás, R; Limão, R; Pedro, E; Lopes, A.

Afiliación

Brás R; Department of Immunoallergology, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
Limão R; Department of Immunoallergology, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
Pedro E; Department of Immunoallergology, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
Lopes A; Department of Immunoallergology, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.

Eur Ann Allergy Clin Immunol ; 2023 Jul 28.

Article en En | MEDLINE | ID: mdl-37503751

Palabras clave

Anti-IL-4/IL-13; atopic dermatitis; dupilumab; pruritus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Eur Ann Allergy Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Portugal

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google